Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Description

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Conditions

Non Small Cell Lung Cancer, Small Cell Lung Carcinoma, NUT Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Condition
Non Small Cell Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02115

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 45 and under at lung cancer diagnosis
  • * Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
  • * Provision of written informed consent
  • * Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks
  • * Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent
  • * Individuals who decline to sign consent
  • * Individuals who are unable to give consent or assent and are without a designated healthcare proxy
  • * Compromise of patient diagnosis or staging if tissue is used for research

Ages Eligible for Study

15 Years to 45 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Pasi A Janne, MD, PhD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2027-08-01